Variable | Time frame considered | All-cause mortality | Death/CPR/MCS/transplantation | Mechanical ventilation/ECLS/CPR/death | ||||||
OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | ||
Age (per year) | At admission | 1.04 | 1.04 to 1.04 | <0.001 | 1.03 | 1.03 to 1.04 | <0.001 | 1.02 | 1.02 to 1.02 | <0.001 |
No of previous viral pneumonias | At admission | |||||||||
None | Reference | Reference | Reference | |||||||
1 | 1.61 | 1.29 to 2.00 | <0.001 | 1.95 | 1.60 to 2.37 | <0.001 | 1.88 | 1.61 to 2.19 | <0.001 | |
2 | 1.46 | 0.71 to 3.01 | 0.30 | 2.10 | 1.20 to 3.67 | 0.009 | 2.64 | 1.82 to 3.84 | <0.001 | |
Female gender | 0.71 | 0.64 to 0.78 | <0.001 | 0.70 | 0.63 to 0.76 | <0.001 | 0.80 | 0.74 to 0.85 | <0.001 | |
CHD complexity | ||||||||||
No CHD | Reference | Reference | Reference | |||||||
Simple defect | 1.10 | 0.65 to 1.86 | 0.73 | 1.78 | 1.22 to 2.59 | 0.003 | 1.99 | 1.61 to 2.47 | <0.001 | |
Moderate complexity | 1.20 | 0.49 to 2.96 | 0.70 | 1.76 | 0.89 to 3.49 | 0.10 | 2.52 | 1.71 to 3.72 | <0.001 | |
Complex CHD | 2.20 | 0.95 to 5.08 | 0.07 | 3.66 | 2.00 to 6.69 | <0.001 | 4.87 | 3.32 to 7.17 | <0.001 | |
Chromosomal anomalies | Prior to admission | 2.88 | 1.67 to 4.94 | <0.001 | 2.17 | 1.37 to 3.44 | 0.001 | 1.82 | 1.35 to 2.45 | <0.001 |
History of cerebral infarction | Prior to admission | 1.08 | 0.93 to 1.25 | 0.31 | 1.04 | 0.90 to 1.20 | 0.57 | 0.95 | 0.83 to 1.08 | 0.41 |
History of myocardial infarction | Prior to admission | 0.90 | 0.72 to 1.12 | 0.33 | 0.95 | 0.78 to 1.17 | 0.66 | 1.00 | 0.83 to 1.20 | 0.97 |
Diagnosis of heart failure | Prior to admission | 1.11 | 0.92 to 1.33 | 0.28 | 1.07 | 0.89 to 1.28 | 0.47 | 1.03 | 0.88 to 1.20 | 0.74 |
History of cancer | Prior to admission | 1.45 | 1.30 to 1.61 | <0.001 | 1.35 | 1.22 to 1.49 | <0.001 | 1.16 | 1.06 to 1.27 | 0.001 |
Immune disease | Prior to admission | 1.07 | 0.86 to 1.35 | 0.54 | 1.07 | 0.86 to 1.32 | 0.55 | 0.98 | 0.82 to 1.16 | 0.80 |
Diabetes | Prior to admission | 0.93 | 0.80 to 1.07 | 0.33 | 0.93 | 0.81 to 1.07 | 0.33 | 0.92 | 0.82 to 1.04 | 0.20 |
Obesity | Prior to admission | 1.00 | 0.88 to 1.13 | 0.96 | 1.09 | 0.97 to 1.23 | 0.14 | 1.24 | 1.12 to 1.36 | <0.001 |
Smoking history | Prior to admission | 1.24 | 1.06 to 1.46 | 0.007 | 1.32 | 1.14 to 1.53 | <0.001 | 1.74 | 1.55 to 1.97 | <0.001 |
History of alcohol abuse | Prior to admission | 1.66 | 1.35 to 2.03 | <0.001 | 1.67 | 1.38 to 2.02 | <0.001 | 1.60 | 1.36 to 1.89 | <0.001 |
Severe renal dysfunction | Prior to admission | 1.04 | 0.78 to 1.37 | 0.80 | 1.10 | 0.84 to 1.43 | 0.49 | 1.23 | 0.98 to 1.54 | 0.07 |
Severe hepatic disease | Prior to admission | — | — | — | 0.92 | 0.19 to 4.51 | 0.92 | 0.77 | 0.19 to 3.07 | 0.71 |
History of cardiac arrhythmias | Prior to admission | 0.89 | 0.78 to 1.01 | 0.07 | 0.88 | 0.78 to 0.99 | 0.04 | 0.87 | 0.78 to 0.96 | 0.007 |
Arterial hypertension | Prior to admission | 0.98 | 0.85 to 1.11 | 0.71 | 0.97 | 0.85 to 1.10 | 0.61 | 1.04 | 0.94 to 1.16 | 0.43 |
Chronic lung disease | Prior to admission | 0.76 | 0.68 to 0.84 | <0.001 | 0.79 | 0.72 to 0.88 | <0.001 | 0.81 | 0.74 to 0.87 | <0.001 |
Documented vaccination | ||||||||||
Influenza | 1 year prior | 0.89 | 0.79 to 0.99 | 0.04 | 0.87 | 0.78 to 0.97 | 0.02 | 0.95 | 0.87 to 1.04 | 0.28 |
Pneumococcal disease | 5 years prior | 0.86 | 0.73 to 1.01 | 0.06 | 0.91 | 0.78 to 1.05 | 0.20 | 0.91 | 0.81 to 1.04 | 0.17 |
Prescription medication | ||||||||||
Cardiac medication | Prior to admission | 1.20 | 1.03 to 1.39 | 0.02 | 1.20 | 1.04 to 1.38 | 0.01 | 1.25 | 1.12 to 1.40 | <0.001 |
Antidepressant or antipsychotic drugs | Prior to admission | 1.31 | 1.17 to 1.46 | <0.001 | 1.25 | 1.12 to 1.39 | <0.001 | 1.16 | 1.06 to 1.27 | 0.001 |
Anticonvulsives | Prior to admission | 1.24 | 1.07 to 1.42 | 0.003 | 1.30 | 1.14 to 1.48 | <0.001 | 1.38 | 1.24 to 1.54 | <0.001 |
NSAIDs | Prior to admission | 0.91 | 0.82 to 1.01 | 0.08 | 0.88 | 0.80 to 0.97 | 0.01 | 0.82 | 0.76 to 0.89 | <0.001 |
Antidiabetics | Prior to admission | 1.15 | 0.98 to 1.35 | 0.10 | 1.20 | 1.03 to 1.40 | 0.02 | 1.29 | 1.13 to 1.48 | <0.001 |
Pulmonary hypertension drugs | Prior to admission | 1.18 | 0.58 to 2.41 | 0.65 | 1.04 | 0.53 to 2.08 | 0.90 | 1.31 | 0.75 to 2.27 | 0.34 |
Anticoagulation vitamin K antagonists | Prior to admission | 0.99 | 0.83 to 1.17 | 0.86 | 1.00 | 0.85 to 1.18 | 0.98 | 1.02 | 0.88 to 1.17 | 0.83 |
Novel oral anticoagulants | Prior to admission | 1.12 | 0.95 to 1.32 | 0.18 | 1.06 | 0.90 to 1.25 | 0.46 | 1.09 | 0.94 to 1.26 | 0.25 |
Antiplatelet drugs | Prior to admission | 1.01 | 0.89 to 1.16 | 0.84 | 0.98 | 0.86 to 1.11 | 0.72 | 0.90 | 0.80 to 1.00 | 0.06 |
Immunosuppressant medication | Prior to admission | 1.49 | 1.33 to 1.67 | <0.001 | 1.31 | 1.18 to 1.46 | <0.001 | 1.19 | 1.09 to 1.29 | <0.001 |
Significant values are in bold.
CHD, congenital heart disease; CPR, cardiopulmonary resuscitation; ECLS, extracorporeal lung support; MCS, mechanical cardiac support; NSAIDs, non-steroidal anti-inflammatory drugs.